Patents by Inventor Katsunori Kitamoto

Katsunori Kitamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzoazepine derivative and medical use thereof
    Patent number: 9586905
    Abstract: A compound having a V2 receptor agonistic activity is provided. Providing a pharmaceutical composition which contains, as an active ingredient, a compound represented by general formula (I) described below: [R1 is formula described below: (A is a lower alkylene group which may be substituted with lower alkyl group; R6 is a hydrogen atom; R7 is a hydroxyl group, an aromatic heterocyclic group which may be substituted with lower alkyl group, carbamoyl group); R2 is a hydrogen atom or lower alkyl group; R3 is lower alkyl group which may be substituted with 1-3 fluorine atoms, or halogen atom; R4 is a five-membered aromatic monocyclic heterocyclic group, five-membered non-aromatic monocyclic heterocyclic group, (provided each heterocyclic groups contain at least one nitrogen atom and may be substituted with a lower alkyl group); and R5 is a lower alkyl group, halogen atom], or pharmacologically acceptable salt thereof.
    Type: Grant
    Filed: December 26, 2013
    Date of Patent: March 7, 2017
    Assignee: SANWA KAGAKU KENKYUSHO CO., LTD.
    Inventors: Katsunori Kitamoto, Nobuyoshi Kasugai, Hiroyo Kataoka, Yasushi Ohsawa, Yuka Kuno, Hiroki Fujieda, Keita Sakai, Hiroki Nagano, Naoki Takahashi, Toru Izuchi, Mitsuaki Takeuchi, Daisuke Kurumazuka, Toshiyuki Miyazawa, Satoko Harada, Izumi Gotoh, Yukiyasu Asano, Yurie Yamada, Morio Okabe
  • NOVEL BENZOAZEPINE DERIVATIVE AND MEDICAL USE THEREOF
    Publication number: 20150291533
    Abstract: A compound having a V2 receptor agonistic activity is provided. Providing a pharmaceutical composition which contains, as an active ingredient, a compound represented by general formula (I) described below: [R1 is formula described below: (A is a lower alkylene group which may be substituted with lower alkyl group; R6 is a hydrogen atom; R7 is a hydroxyl group, an aromatic heterocyclic group which may be substituted with lower alkyl group, carbamoyl group); R2 is a hydrogen atom or lower alkyl group; R3 is lower alkyl group which may be substituted with 1-3 fluorine atoms, or halogen atom; R4 is a five-membered aromatic monocyclic heterocyclic group, five-membered non-aromatic monocyclic heterocyclic group, (provided each heterocyclic groups contain at least one nitrogen atom and may be substituted with a lower alkyl group); and R5 is a lower alkyl group, halogen atom], or pharmacologically acceptable salt thereof.
    Type: Application
    Filed: December 26, 2013
    Publication date: October 15, 2015
    Inventors: Katsunori Kitamoto, Nobuyoshi Kasugai, Hiroyo Kataoka, Yasushi Ohsawa, Yuka Kuno, Hiroki Fujieda, Keita Sakai, Hiroki Nagano, Naoki Takahashi, Toru Izuchi, Mitsuaki Takeuchi, Daisuke Kurumazuka, Toshiyuki Miyazawa, Satoko Harada, Izumi Gotoh, Yukiyasu Asano, Yurie Yamada, Morio Okabe